{"id":"https://openalex.org/W1970004454","doi":"https://doi.org/10.1111/febs.13103","title":"Combining an amyloid\u2010beta (A\u03b2) cleaving enzyme inhibitor with a \u03b3\u2010secretase modulator results in an additive reduction of A\u03b2 production","display_name":"Combining an amyloid\u2010beta (A\u03b2) cleaving enzyme inhibitor with a \u03b3\u2010secretase modulator results in an additive reduction of A\u03b2 production","publication_year":2014,"publication_date":"2014-10-10","ids":{"openalex":"https://openalex.org/W1970004454","doi":"https://doi.org/10.1111/febs.13103","mag":"1970004454","pmid":"https://pubmed.ncbi.nlm.nih.gov/25303711"},"language":"en","primary_location":{"id":"doi:10.1111/febs.13103","doi":"https://doi.org/10.1111/febs.13103","is_oa":false,"landing_page_url":"https://doi.org/10.1111/febs.13103","pdf_url":null,"source":{"id":"https://openalex.org/S37672443","display_name":"FEBS Journal","issn_l":"1742-464X","issn":["1742-464X","1742-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS Journal","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085816874","display_name":"Kia Str\u00f6mberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kia Str\u00f6mberg","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013407044","display_name":"Susanna Eketj\u00e4ll","orcid":"https://orcid.org/0000-0003-2165-1251","observed_orcids":["https://orcid.org/0000-0003-2165-1251"]},"institutions":[{"id":"https://openalex.org/I2800139495","display_name":"Science for Life Laboratory","ror":"https://ror.org/04ev03g22","country_code":"SE","type":"facility","lineage":["https://openalex.org/I2800139495"]},{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Susanna Eketj\u00e4ll","raw_affiliation_strings":["AstraZeneca Translational Science Centre; Science for Life Laboratory; Solna Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Translational Science Centre; Science for Life Laboratory; Solna Sweden","institution_ids":["https://openalex.org/I2800139495","https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073732733","display_name":"Biljana Georgievska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Biljana Georgievska","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060128316","display_name":"Karin Tunblad","orcid":"https://orcid.org/0009-0004-3816-2678","observed_orcids":["https://orcid.org/0009-0004-3816-2678"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Karin Tunblad","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052677969","display_name":"Kristina Eliason","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Kristina Eliason","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004735864","display_name":"Fredrik Olsson","orcid":"https://orcid.org/0000-0002-7569-7901","observed_orcids":["https://orcid.org/0000-0002-7569-7901"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Fredrik Olsson","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109084202","display_name":"Ann\u2010Cathrin Rades\u00e4ter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Ann\u2010Cathrin Rades\u00e4ter","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072982592","display_name":"Rebecka Klintenberg","orcid":"https://orcid.org/0009-0002-0514-8082","observed_orcids":["https://orcid.org/0009-0002-0514-8082"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Rebecka Klintenberg","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047686129","display_name":"Per I. Arvidsson","orcid":"https://orcid.org/0000-0002-9453-6812","observed_orcids":["https://orcid.org/0000-0002-9453-6812"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Per I. Arvidsson","raw_affiliation_strings":["Project Management, AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Project Management, AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111915957","display_name":"Stefan von Berg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Stefan von Berg","raw_affiliation_strings":["Department of Medicinal Chemistry R&I iMed AstraZeneca R&D M\u00f6lndal Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry R&I iMed AstraZeneca R&D M\u00f6lndal Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077343101","display_name":"Johanna M. F\u00e4lting","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Johanna F\u00e4lting","raw_affiliation_strings":["Project Management, AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Project Management, AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009299964","display_name":"Richard F. Cowburn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Richard F. Cowburn","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068920108","display_name":"Michael A. Dabrowski","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"Michael Dabrowski","raw_affiliation_strings":["Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience AstraZeneca R&D CNS/Pain iMED S\u00f6dert\u00e4lje Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5068920108"],"corresponding_institution_ids":["https://openalex.org/I4210143795"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":1.1011,"has_fulltext":false,"cited_by_count":23,"citation_normalized_percentile":{"value":0.70482503,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"282","issue":"1","first_page":"65","last_page":"73"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10009","display_name":"Dementia and Cognitive Impairment Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.8389999866485596},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8600000143051147},{"id":"https://openalex.org/keywords/bace1-inhibitors","display_name":"BACE1 inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/gamma-secretase-modulators","display_name":"\u03b3-secretase modulators","score":0.9629999995231628},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":0.7239999771118164},{"id":"https://openalex.org/keywords/app-processing","display_name":"APP processing","score":0.9100000262260437},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/additive-drug-effects","display_name":"additive drug effects","score":0.753000020980835},{"id":"https://openalex.org/keywords/cortical-neurons","display_name":"cortical neurons","score":0.8050000071525574},{"id":"https://openalex.org/keywords/c57bl-6-mice","display_name":"C57BL/6 mice","score":0.8450000286102295},{"id":"https://openalex.org/keywords/disease-modification","display_name":"disease modification","score":0.42899999022483826}],"concepts":[{"id":"https://openalex.org/C36103677","wikidata":"https://www.wikidata.org/wiki/Q4749551","display_name":"Amyloid precursor protein secretase","level":5,"score":0.7790035009384155},{"id":"https://openalex.org/C2778171954","wikidata":"https://www.wikidata.org/wiki/Q15328541","display_name":"Gamma secretase","level":2,"score":0.6128537654876709},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5050495266914368},{"id":"https://openalex.org/C31705614","wikidata":"https://www.wikidata.org/wiki/Q423510","display_name":"Amyloid precursor protein","level":4,"score":0.5011305809020996},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49855494499206543},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.49484699964523315},{"id":"https://openalex.org/C2776156579","wikidata":"https://www.wikidata.org/wiki/Q417667","display_name":"Amyloid beta","level":3,"score":0.4670502245426178},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.45548126101493835},{"id":"https://openalex.org/C177907266","wikidata":"https://www.wikidata.org/wiki/Q17155455","display_name":"P3 peptide","level":5,"score":0.4319859445095062},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.4149511754512787},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.33651202917099},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.30856025218963623},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2439291775226593},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.18257489800453186},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15279728174209595},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001921","descriptor_name":"Brain","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011480","descriptor_name":"Protease Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011714","descriptor_name":"Pyrans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016282","descriptor_name":"Aspartic Acid Endopeptidases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D016282","descriptor_name":"Aspartic Acid Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053829","descriptor_name":"Amyloid Precursor Protein Secretases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D057809","descriptor_name":"HEK293 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/febs.13103","doi":"https://doi.org/10.1111/febs.13103","is_oa":false,"landing_page_url":"https://doi.org/10.1111/febs.13103","pdf_url":null,"source":{"id":"https://openalex.org/S37672443","display_name":"FEBS Journal","issn_l":"1742-464X","issn":["1742-464X","1742-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS Journal","raw_type":"journal-article"},{"id":"pmid:25303711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25303711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS journal","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.979200005531311,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W1483703465","https://openalex.org/W1534001036","https://openalex.org/W1579606275","https://openalex.org/W1626267121","https://openalex.org/W1644122431","https://openalex.org/W1965013631","https://openalex.org/W1970865922","https://openalex.org/W1976333571","https://openalex.org/W1976355675","https://openalex.org/W1977688919","https://openalex.org/W1989453114","https://openalex.org/W2016123010","https://openalex.org/W2017917068","https://openalex.org/W2019010572","https://openalex.org/W2025563134","https://openalex.org/W2026053103","https://openalex.org/W2032876681","https://openalex.org/W2033354781","https://openalex.org/W2037318207","https://openalex.org/W2041573170","https://openalex.org/W2042082068","https://openalex.org/W2062283435","https://openalex.org/W2071039396","https://openalex.org/W2084511688","https://openalex.org/W2084972185","https://openalex.org/W2089824266","https://openalex.org/W2093682315","https://openalex.org/W2103071556","https://openalex.org/W2109727228","https://openalex.org/W2113690827","https://openalex.org/W2122997297","https://openalex.org/W2124097986","https://openalex.org/W2133019124","https://openalex.org/W2134365974","https://openalex.org/W2136903466","https://openalex.org/W2154144191","https://openalex.org/W2154755614","https://openalex.org/W2155237226","https://openalex.org/W2162815565","https://openalex.org/W4247759744"],"related_works":["https://openalex.org/W2003469214","https://openalex.org/W2071039396","https://openalex.org/W2319520495","https://openalex.org/W2523729690","https://openalex.org/W2536993359","https://openalex.org/W2726709044","https://openalex.org/W3138418840","https://openalex.org/W2059008719","https://openalex.org/W4411189117","https://openalex.org/W1993347987"],"abstract_inverted_index":{"A":[0],"major":[1],"hallmark":[2],"of":[3,10,24,47,80,87,96,124,162,169,180,195],"Alzheimer's":[4],"disease":[5,62],"(AD)":[6],"is":[7,83,187],"the":[8,25,30,37,50,98,145,156,167,170,193],"deposition":[9],"amyloid-\u03b2":[11],"(A\u03b2)":[12],"peptides":[13,18],"in":[14,48,160,222],"amyloid":[15,26,32,182],"plaques.":[16],"A\u03b2":[17,204],"are":[19,54],"produced":[20],"by":[21,29,206],"sequential":[22],"cleavage":[23],"precursor":[27,183],"protein":[28,184],"\u03b2":[31],"cleaving":[33],"enzyme":[34],"(BACE)":[35],"and":[36,65,113,132,211],"\u03b3-secretase":[38],"(\u03b3-sec)":[39],"complex.":[40],"Pharmacological":[41,78],"treatments":[42],"that":[43,121,177,202],"decrease":[44],"brain":[45,163],"levels":[46,165],"particular":[49],"toxic":[51],"A\u03b242":[52,140,164],"peptide":[53],"thought":[55],"to":[56,103,152],"be":[57,102,215],"promising":[58],"approaches":[59],"for":[60,219],"AD":[61,223],"modification.":[63,224],"Potent":[64],"selective":[66],"BACE1":[67,130],"inhibitors":[68],"as":[69,71],"well":[70],"\u03b3-sec":[72],"modulators":[73],"(GSMs)":[74],"have":[75],"been":[76],"designed.":[77],"intervention":[79,221],"secretase":[81],"function":[82],"not":[84],"without":[85,189],"risks":[86],"either":[88],"on-":[89],"or":[90],"off-target":[91],"adverse":[92,116],"effects.":[93],"One":[94],"way":[95],"improving":[97],"therapeutic":[99,220],"window":[100],"could":[101,214],"combine":[104],"treatment":[105,123,158,172],"on":[106,139,197],"multiple":[107],"targets,":[108],"using":[109],"smaller":[110],"individual":[111,146,171,198],"doses":[112],"thereby":[114],"minimizing":[115],"effect":[117,138],"liability.":[118],"We":[119,148,200],"show":[120,176],"combined":[122,157],"primary":[125],"cortical":[126],"neurons":[127],"with":[128,144,192],"a":[129,133,208,212,216],"inhibitor":[131,210],"GSM":[134,213],"gives":[135],"an":[136],"additive":[137],"level":[141],"change":[142],"compared":[143],"treatments.":[147],"extend":[149],"this":[150],"finding":[151],"C57BL/6":[153],"mice,":[154],"where":[155],"results":[159,175],"reduction":[161],"reflecting":[166],"sum":[168],"efficacies.":[173],"These":[174],"pharmacological":[178],"targeting":[179,203],"two":[181],"processing":[185],"steps":[186],"feasible":[188],"negatively":[190],"interfering":[191],"mechanism":[194],"action":[196],"targets.":[199],"conclude":[201],"production":[205],"combining":[207],"BACE":[209],"viable":[217],"approach":[218]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}